BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Sep 27, 2024; 16(9): 1245-1257
Published online Sep 27, 2024. doi: 10.4254/wjh.v16.i9.1245
Drainage of ascites in cirrhosis
Zheng-Lei Xu, Xi-Min Lin, Hao-Tian Zeng, Yue-Ming Peng, Jia-Xing Yang
Jia-Xing Yang, Hao-Tian Zeng, Xi-Min Lin, Department of Gastroenterology, The Second Clinical Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China
Yue-Ming Peng, Department of Nursing, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China
Zheng-Lei Xu, Department of Gastroenterology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, Shenzhen 518000, Guangdong Province, China
Co-first authors: Jia-Xing Yang and Yue-Ming Peng.
Author contributions: Yang JX and Peng YM contributed equally to this work; Yang JX, Zeng HT, Lin XM, Xu ZL wrote the manuscript; All authors have read and approved the final manuscript.
Supported by Sanming Project of Medicine in Shenzhen, No. SZSM202211029.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Zheng-Lei Xu, MD, Assistant Professor, Chief Doctor, Department of Gastroenterology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, No. 1017 Dongmen North Road, Shenzhen 518000, Guangdong Province, China. 78249073@qq.com
Received: July 3, 2024
Revised: July 20, 2024
Accepted: July 29, 2024
Published online: September 27, 2024
Processing time: 82 Days and 7.7 Hours
Abstract

For cirrhotic refractory ascites, diuretics combined with albumin and vasoactive drugs are the first-line choice for ascites management. However, their therapeutic effects are limited, and most refractory ascites do not respond to medication treatment, necessitating consideration of drainage or surgical interventions. Consequently, numerous drainage methods for cirrhotic ascites have emerged, including large-volume paracentesis, transjugular intrahepatic portosystemic shunt, peritoneovenous shunt, automated low-flow ascites pump, cell-free and concentrated ascites reinfusion therapy, and peritoneal catheter drainage. This review introduces the advantages and disadvantages of these methods in different aspects, as well as indications and contraindications for this disease.

Keywords: Liver cirrhosis ascites; Large-volume paracentesis; Transjugular intrahepatic portosystemic shunt; Peritoneovenous shunt; Automated low-flow ascites pump; Cell-free and concentrated ascites reinfusion therapy; Peritoneal catheter drainage

Core Tip: For cirrhotic refractory ascites, peritoneovenous shunt is rarely used due to its high complication rate. Initial treatment for most refractory ascites prioritizes large-volume paracentesis combined with albumin infusion and peritoneal catheter drainage. If these treatments are ineffective or result in severe complications, transjugular intrahepatic portosystemic shunt or automated low-flow ascites pump may be considered. Cell-free and concentrated ascites reinfusion therapy requires further validation for suitability.